Lancemaside A inhibits lipopolysaccharide-induced inflammation by targeting LPS/TLR4 complex.
J Cell Biochem. 2010 Nov 1;111(4):865-71. doi: 10.1002/jcb.22773.
J Cell Biochem. 2010.
PMID: 20665542